ArticleAdvances in therapy2024

Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis.

A Gordon Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.